• Passionate about HIV vaccine research

    Professor Morris speaks about her goal of being part of the team that discovers an HIV vaccine and her highly acclaimed scientific work on broadly neutralising antibodies. Dr John Mascola, Director of the Vaccine Research Center and member of the CAPRISA scientific advisory board, said, “When we do finally learn how to make an effective HIV vaccine, it is likely that we will look back at Lynn’s work as the pivotal first step toward understanding how to generate protective antibodies against HIV.”

    The full article by Tony Kirby can be accessed here:


    Share this article


Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.